Billions On The Move: Tracking Market Cap Changes In Top Cannabis Firms After DEA Rescheduling Announcement
Portfolio Pulse from Nicolás Jose Rodriguez
Following the DEA's announcement to reschedule cannabis, the market cap of major cannabis firms has seen significant changes. Curaleaf, Canopy, Tilray, Aurora, Green Thumb Industries, and Trulieve have experienced fluctuations in market capitalization since their public debuts. The total economic impact of regulated marijuana sales in the U.S. is expected to surpass $112.4 billion in 2024, with sales forecasted to reach $32.1 billion. Market cap growth varies among companies, with some experiencing decreases and others increases.
May 01, 2024 | 6:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Green Thumb Industries' market cap increased from $2.05 billion in 2018 to $3.60 billion in 2024, showing growth.
Green Thumb Industries' market cap growth indicates a positive impact, likely due to strategic expansions and favorable market positioning.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Trulieve's market cap showed growth from $1.31 billion in 2019 to $1.97 billion in 2024, indicating a positive trend.
Trulieve's market cap increase suggests a positive short-term impact, possibly due to effective business strategies and market expansion.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Aurora's market cap dramatically fell from $18.55 billion in 2017 to $439.30 million in 2024, indicating a severe decrease.
Aurora's significant market cap reduction reflects intense industry volatility and challenges in maintaining growth and profitability.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
NEGATIVE IMPACT
Canopy's market cap decreased from $5.40 billion in 2018 to $1.36 billion in 2024, indicating significant market cap loss.
Canopy's substantial market cap decrease reflects broader sector challenges and possibly investor skepticism about future growth prospects.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Curaleaf's market cap fluctuated, peaking at $5 billion at its debut and settling at $4.63 billion in 2024, indicating a decrease.
The decrease in Curaleaf's market cap from its public debut to 2024 suggests a negative short-term impact, likely due to market volatility and regulatory changes.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Tilray's market cap saw a peak in 2018 at $6.57 billion, dropping to $1.91 billion by 2024, indicating a negative trend.
Tilray's decline in market cap over the years suggests a negative impact, potentially due to regulatory hurdles and market saturation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90